IT1314185B1 - Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi - Google Patents

Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi

Info

Publication number: IT1314185B1
Authority: IT; Italy
Prior art keywords: pharmaceutical composition; aqueous media; soluble; administration; actively
Prior art date: 1998-08-21

Application number

IT1999MI001826A

Other languages

English (en)

Inventor

Bruijn Karel De

Gunter Engel

Hans-Jurgen Pfannkuche

Michael Thewissen

Christian Vitzling

Othmar Zuger

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-08-21

Filing date

1999-08-19

Publication date

2002-12-06

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27451823&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IT1314185(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-08-21 Priority claimed from GBGB9818340.3A external-priority patent/GB9818340D0/en

1998-10-27 Priority claimed from GBGB9823477.6A external-priority patent/GB9823477D0/en

1999-05-05 Priority claimed from GBGB9910320.2A external-priority patent/GB9910320D0/en

1999-05-12 Priority claimed from GBGB9911059.5A external-priority patent/GB9911059D0/en

1999-08-19 Application filed by Novartis Ag filed Critical Novartis Ag

1999-08-19 Publication of ITMI991826A0 publication Critical patent/ITMI991826A0/it

2001-02-19 Publication of ITMI991826A1 publication Critical patent/ITMI991826A1/it

2002-12-06 Application granted granted Critical

2002-12-06 Publication of IT1314185B1 publication Critical patent/IT1314185B1/it

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Biophysics (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Indole Compounds (AREA)
Cosmetics (AREA)
Macromonomer-Based Addition Polymer (AREA)
Peptides Or Proteins (AREA)

IT1999MI001826A 1998-08-21 1999-08-19 Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi IT1314185B1 (it)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GBGB9818340.3A GB9818340D0 (en)	1998-08-21	1998-08-21	Organic compounds
GBGB9823477.6A GB9823477D0 (en)	1998-10-27	1998-10-27	Organic compounds
GBGB9910320.2A GB9910320D0 (en)	1999-05-05	1999-05-05	Organic compounds
GBGB9911059.5A GB9911059D0 (en)	1999-05-12	1999-05-12	Organic compounds

Publications (3)

Publication Number	Publication Date
ITMI991826A0 ITMI991826A0 (it)	1999-08-19
ITMI991826A1 ITMI991826A1 (it)	2001-02-19
IT1314185B1 true IT1314185B1 (it)	2002-12-06

Family

ID=27451823

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IT1999MI001826A IT1314185B1 (it)	1998-08-21	1999-08-19	Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi

Country Status (29)

Country	Link
US (4)	US20030236183A1 (it)
EP (1)	EP1104289B1 (it)
JP (1)	JP4048024B2 (it)
KR (1)	KR100529659B1 (it)
CN (2)	CN1165293C (it)
AT (1)	ATE316782T1 (it)
AU (4)	AU762829B2 (it)
BG (1)	BG65322B1 (it)
BR (1)	BR9913135A (it)
CA (1)	CA2338794C (it)
CZ (1)	CZ300647B6 (it)
DE (1)	DE69929703T2 (it)
DK (1)	DK1104289T3 (it)
EE (1)	EE05054B1 (it)
ES (1)	ES2257869T3 (it)
FR (3)	FR2782454B1 (it)
HR (1)	HRP20010123B1 (it)
HU (1)	HU228179B1 (it)
ID (1)	ID28510A (it)
IL (1)	IL141236A0 (it)
IS (1)	IS2369B (it)
IT (1)	IT1314185B1 (it)
NO (1)	NO328756B1 (it)
NZ (1)	NZ509832A (it)
PL (2)	PL200132B1 (it)
RS (1)	RS50104B (it)
SK (1)	SK285255B6 (it)
TR (3)	TR200400187T2 (it)
WO (1)	WO2000010526A2 (it)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2002004411A1 (en)	2000-07-07	2002-01-17	The Administrators Of The Tulane Educational Fund	Methods for protection of stratified squamous epithelium against injury by noxious substances and novel agents for use therefor
AU2002231627A1 (en) *	2000-11-24	2002-06-03	Janssen Pharmaceutica N.V.	Use of a triple combination comprising a 5HT3 antagonist, a 5HT4 agonist and a laxative for promoting intestinal lavage
EP1321142A1 (en) *	2001-12-21	2003-06-25	Novartis AG	Solid pharmaceutical composition for oral administration of Tegaserod
CA2517310C (en) *	2003-02-28	2015-11-24	Chugai Seiyaku Kabushiki Kaisha	Stabilized protein-containing formulations comprising a poloxamer
WO2004085393A1 (en) *	2003-03-25	2004-10-07	Hetero Drugs Limited	Novel crystalline forms of tegaserod maleate
GB0307440D0 (en) *	2003-03-31	2003-05-07	Novartis Ag	Organic compounds
MY137386A (en) *	2003-07-24	2009-01-30	Novartis Ag	Stable modifications of tegaserod hydrogen maleate
US8597703B2 (en)	2005-05-23	2013-12-03	Kraft Foods Global Brands Llc	Delivery system for active components as part of an edible composition including a ratio of encapsulating material and active component
US20050112236A1 (en)	2003-11-21	2005-05-26	Navroz Boghani	Delivery system for active components as part of an edible composition having preselected tensile strength
US8389032B2 (en)	2005-05-23	2013-03-05	Kraft Foods Global Brands Llc	Delivery system for active components as part of an edible composition having selected particle size
US8591974B2 (en)	2003-11-21	2013-11-26	Kraft Foods Global Brands Llc	Delivery system for two or more active components as part of an edible composition
US8591973B2 (en)	2005-05-23	2013-11-26	Kraft Foods Global Brands Llc	Delivery system for active components and a material having preselected hydrophobicity as part of an edible composition
US8591972B2 (en)	2005-05-23	2013-11-26	Kraft Foods Global Brands Llc	Delivery system for coated active components as part of an edible composition
US8591968B2 (en)	2005-05-23	2013-11-26	Kraft Foods Global Brands Llc	Edible composition including a delivery system for active components
US8216610B2 (en)	2004-05-28	2012-07-10	Imaginot Pty Ltd.	Oral paracetamol formulations
WO2007059591A1 (en)	2005-11-28	2007-05-31	Imaginot Pty Ltd	Oral therapeutic compound delivery system
US12186426B2 (en)	2009-10-30	2025-01-07	Ix Biopharma Ltd.	Solid dosage form
EP3254676B1 (en)	2009-10-30	2018-11-28	IX Biopharma Ltd	Fast dissolving solid dosage form
US20140296831A1 (en)	2011-08-20	2014-10-02	Fred Göbel	Trans-anal inflow catheter and method for intermittently triggering a reflex-coordinated defecation
UA118339C2 (uk) *	2012-09-03	2019-01-10	Біогайа Аб	Бактеріальний штам lactobacillus gasseri для лікування порушення моторики кишечнику (варіанти)

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US552398A (en) *		1895-12-31		Riveting-machine
JP2708803B2 (ja) *	1987-09-02	1998-02-04	中外製薬株式会社	持続放出製剤
ES2075403T3 (es) *	1990-08-24	1995-10-01	Spirig Ag Pharmazeutische Prap	Procedimiento para la fabricacion de pellets.
HUT64023A (en) *	1991-03-22	1993-11-29	Sandoz Ag	Process for producing aminoguanidine derivatives and pharmaceutical compositions comprising such compounds
US5523289A (en) *	1991-04-15	1996-06-04	Abbott Laboratories	Pharmaceutical composition
US20020128172A1 (en) *	1991-12-21	2002-09-12	Smithkline Beecham Plc	Use of 5-HT4 modulators for the manufacture of a medicament for the treatment of the bladder diseases
FR2710915B1 (fr) *	1993-10-04	1995-11-24	Synthelabo	Dérivés de pipéridine, leur préparation et leur utilisation en thérapeutique.
TW270114B (it) *	1993-10-22	1996-02-11	Hoffmann La Roche
US5399562A (en) *	1994-02-04	1995-03-21	G. D. Searle & Co.	Indolones useful as serotonergic agents
JPH0820586A (ja) *	1994-07-05	1996-01-23	Sanwa Kagaku Kenkyusho Co Ltd	１−アザビシクロ［３．３．０］オクタン誘導体、その塩及び製法並びに用途
CA2205442C (en) *	1994-12-01	2003-01-21	David R. Friend	Nsaid delivery employing a powdered hydrocolloid gum obtainable from higher plants
US5654320A (en) *	1995-03-16	1997-08-05	Eli Lilly And Company	Indazolecarboxamides
IL117438A (en) *	1995-03-16	2001-12-23	Lilly Co Eli	Indazolecarboxamides, their preparation and pharmaceutical compositions containing them
JPH09194374A (ja) *	1995-11-14	1997-07-29	Taisho Pharmaceut Co Ltd	消化器疾患治療剤
US5705190A (en) *	1995-12-19	1998-01-06	Abbott Laboratories	Controlled release formulation for poorly soluble basic drugs
US5739151A (en) *	1996-07-19	1998-04-14	Sepracor Inc.	Method for treating emesis and central nervous system disorders using optically pure (+) norcisapride
FR2753196B1 (fr) *	1996-09-12	1998-10-23	Synthelabo	Derives d'indazole tricyclique, leur preparation et leur application en therapeutique
CA2315088A1 (en) *	1997-12-19	1999-07-01	Smithkline Beecham Corporation	Process for manufacturing bite-dispersion tablets
US20010014352A1 (en) *	1998-05-27	2001-08-16	Udit Batra	Compressed tablet formulation
EP1321142A1 (en) *	2001-12-21	2003-06-25	Novartis AG	Solid pharmaceutical composition for oral administration of Tegaserod

1999
- 1999-08-19 CA CA002338794A patent/CA2338794C/en not_active Expired - Lifetime
- 1999-08-19 ES ES99942892T patent/ES2257869T3/es not_active Expired - Lifetime
- 1999-08-19 CN CNB998099244A patent/CN1165293C/zh not_active Expired - Lifetime
- 1999-08-19 IT IT1999MI001826A patent/IT1314185B1/it active
- 1999-08-19 SK SK243-2001A patent/SK285255B6/sk not_active IP Right Cessation
- 1999-08-19 WO PCT/EP1999/006083 patent/WO2000010526A2/en not_active Ceased
- 1999-08-19 NZ NZ509832A patent/NZ509832A/en not_active IP Right Cessation
- 1999-08-19 IL IL14123699A patent/IL141236A0/xx not_active IP Right Cessation
- 1999-08-19 HR HR20010123A patent/HRP20010123B1/xx not_active IP Right Cessation
- 1999-08-19 KR KR10-2001-7002161A patent/KR100529659B1/ko not_active Expired - Lifetime
- 1999-08-19 TR TR2004/00187T patent/TR200400187T2/xx unknown
- 1999-08-19 TR TR2001/00361T patent/TR200100361T2/xx unknown
- 1999-08-19 PL PL380173A patent/PL200132B1/pl unknown
- 1999-08-19 JP JP2000565848A patent/JP4048024B2/ja not_active Expired - Lifetime
- 1999-08-19 HU HU0103431A patent/HU228179B1/hu unknown
- 1999-08-19 DE DE69929703T patent/DE69929703T2/de not_active Expired - Lifetime
- 1999-08-19 RS YUP-87/01A patent/RS50104B/sr unknown
- 1999-08-19 CZ CZ20010619A patent/CZ300647B6/cs not_active IP Right Cessation
- 1999-08-19 AT AT99942892T patent/ATE316782T1/de active
- 1999-08-19 TR TR2001/02259T patent/TR200102259T2/xx unknown
- 1999-08-19 BR BR9913135-8A patent/BR9913135A/pt not_active Application Discontinuation
- 1999-08-19 EE EEP200100104A patent/EE05054B1/xx unknown
- 1999-08-19 PL PL99346764A patent/PL194069B1/pl unknown
- 1999-08-19 ID IDW20010318A patent/ID28510A/id unknown
- 1999-08-19 AU AU56232/99A patent/AU762829B2/en not_active Expired
- 1999-08-19 DK DK99942892T patent/DK1104289T3/da active
- 1999-08-19 EP EP99942892A patent/EP1104289B1/en not_active Expired - Lifetime
- 1999-08-19 CN CNA2004100638733A patent/CN1589906A/zh active Pending
- 1999-08-20 FR FR9910666A patent/FR2782454B1/fr not_active Expired - Lifetime
- 1999-11-26 FR FR9914897A patent/FR2784899B1/fr not_active Expired - Lifetime
2000
- 2000-02-20 IS IS5851A patent/IS2369B/is unknown
- 2000-08-21 FR FR0010748A patent/FR2799123B1/fr not_active Expired - Lifetime
2001
- 2001-02-14 BG BG105257A patent/BG65322B1/bg unknown
- 2001-02-20 NO NO20010863A patent/NO328756B1/no not_active IP Right Cessation
2003
- 2003-07-15 US US10/620,178 patent/US20030236183A1/en not_active Abandoned
- 2003-09-22 AU AU2003248212A patent/AU2003248212A1/en not_active Abandoned
2006
- 2006-01-06 AU AU2006200048A patent/AU2006200048A1/en not_active Abandoned
2007
- 2007-11-29 US US11/947,769 patent/US20080075773A1/en not_active Abandoned
2009
- 2009-02-04 AU AU2009200403A patent/AU2009200403A1/en not_active Abandoned
2011
- 2011-11-23 US US13/303,459 patent/US20120071537A1/en not_active Abandoned
2013
- 2013-01-31 US US13/755,444 patent/US20130158092A1/en not_active Abandoned

Also Published As

Publication number	Publication date
PL200132B1 (pl)	2008-12-31
ITMI991826A1 (it)	2001-02-19
SK285255B6 (sk)	2006-09-07
HUP0103431A2 (hu)	2002-01-28
HRP20010123B1 (hr)	2010-11-30
FR2784899A1 (fr)	2000-04-28
JP4048024B2 (ja)	2008-02-13
BG105257A (en)	2001-11-30
EP1104289A2 (en)	2001-06-06
JP2002523351A (ja)	2002-07-30
SK2432001A3 (en)	2001-09-11
ATE316782T1 (de)	2006-02-15
EP1104289B1 (en)	2006-02-01
CZ2001619A3 (en)	2001-05-16
IS5851A (is)	2001-01-20
US20120071537A1 (en)	2012-03-22
CZ300647B6 (cs)	2009-07-08
AU2003248212A1 (en)	2003-10-30
KR20010079668A (ko)	2001-08-22
DE69929703T2 (de)	2007-02-22
FR2784899B1 (fr)	2001-08-17
CN1589906A (zh)	2005-03-09
FR2782454A1 (fr)	2000-02-25
NO328756B1 (no)	2010-05-03
WO2000010526A3 (en)	2000-09-08
AU2009200403A1 (en)	2009-02-26
PL194069B1 (pl)	2007-04-30
ES2257869T3 (es)	2006-08-01
AU2006200048A1 (en)	2006-02-02
NZ509832A (en)	2003-11-28
CN1165293C (zh)	2004-09-08
TR200102259T2 (tr)	2002-06-21
NO20010863L (no)	2001-03-26
HUP0103431A3 (en)	2002-02-28
IL141236A0 (en)	2002-03-10
EE200100104A (et)	2002-06-17
HU228179B1 (en)	2013-01-28
TR200400187T2 (tr)	2006-11-21
ID28510A (id)	2001-05-31
US20080075773A1 (en)	2008-03-27
CA2338794C (en)	2009-01-20
CA2338794A1 (en)	2000-03-02
CN1323200A (zh)	2001-11-21
NO20010863D0 (no)	2001-02-20
AU762829B2 (en)	2003-07-03
US20130158092A1 (en)	2013-06-20
RS50104B (sr)	2009-01-22
BR9913135A (pt)	2001-05-08
IS2369B (is)	2008-06-15
PL346764A1 (en)	2002-02-25
US20030236183A1 (en)	2003-12-25
TR200100361T2 (tr)	2001-06-21
FR2799123B1 (fr)	2005-12-02
EE05054B1 (et)	2008-08-15
KR100529659B1 (ko)	2005-11-21
FR2799123A1 (fr)	2001-04-06
ITMI991826A0 (it)	1999-08-19
HK1038179A1 (en)	2002-03-08
DK1104289T3 (da)	2006-05-15
YU8701A (sh)	2003-12-31
FR2782454B1 (fr)	2005-12-02
AU5623299A (en)	2000-03-14
BG65322B1 (bg)	2008-02-29
WO2000010526A2 (en)	2000-03-02
HRP20010123A2 (en)	2002-02-28
DE69929703D1 (de)	2006-04-13

Publication	Publication Date	Title
IT1314185B1 (it)	2002-12-06	Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi
NZ501950A (en)	2003-04-29	Medicinal compositions for application to mucosa
ATE224717T1 (de)	2002-10-15	Oral anzuwendende arzneizubereitungen enthaltend eine benzhydrylpiperazine und eine zyklodextrin
EP1233756A4 (en)	2007-12-26	SOLID EXCIPIENTS FOR IMPROVED ADMINISTRATION OF ACTIVE INGREDIENTS IN PHARMACEUTICAL COMPOSITIONS
BR0107147A (pt)	2002-06-18	Composições farmacêuticas de drogas anti-tuberculosas e processo para as suas preparações
FI971776A0 (fi)	1997-04-25	Yhdisteet ja koostumukset aktiivisten aineiden antamiseksi
EP1100522A4 (en)	2003-01-08	ADMINISTRATION OF ACTIVE AGENTS OVER THE LUNG
ES2195344T3 (es)	2003-12-01	Composicion farmaceutica que presenta una actividad antitumoral mejorada y/o efectos secundarios reducidos, que contiene un agente antitumoral y un derivado de acido hidroximico.
CY1110906T1 (el)	2015-06-10	Φαρμακευτικη συνθεση για ρινικη χορηγηση φεντανυλης
BRPI0008228B8 (pt)	2021-05-25	composição farmacêutica contendo n-benzoil estaurosporina e agentes solubilizantes
MXPA03005221A (es)	2004-03-26	Composicion farmaceutica de dronedarona para administracion parenteral.
ATE226065T1 (de)	2002-11-15	Feste instant-release-darreichungsformen und verfahren zu ihrer herstellung
UY27373A1 (es)	2003-02-28	Formulaciones de interferón beta-humano
MXPA01011842A (es)	2003-09-04	Composiciones farmaceuticas para la administracion oral de floroglucinol y preparacion de las mismas.
BR0011845A (pt)	2002-03-05	Complexo farmacêutico
DK1231908T3 (da)	2004-06-14	Farmaceutisk præparat, der omfatter en NO-donorforbindelse samt anvendelse heraf
DE60007074D1 (de)	2004-01-22	Sulfatierte phosphatidylinositole, ihre herstellung und verwendung
TR200003451T2 (tr)	2001-04-20	Pirimidin-Aminometil-Piridin Türevleri, Hazırlanmaları ve helikobakter bakterinin kontrolünde kullanımları
DK0742716T3 (da)	2003-06-16	Farmaceutisk sammensætning til systemisk transdermal indgivelse med det aktive middel morphin-6-glucuronid
MY152490A (en)	2014-10-15	New oral formulation
HUP0202888A2 (hu)	2002-12-28	Xenogén oligo- és/vagy poliribonukleotidokat tartalmazó gyógyszerkészítmény
ECSP993104A (es)	1999-10-06	Nueva formulacion oral
CR6300A (es)	2004-06-08	Nueva formulacion oral